Algo version: 0.98b
PT Jayamas Medica is listed at the JKT Exchange
PT Jayamas Medica [OMED.JK]
JKT Sector: Healthcare Industry:Medical Instruments Supplies

Is PT Jayamas Medica stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, PT Jayamas Medica pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Thursday 20th of June 2024 were paid IDR2.88 per share. Over the last 2 times between 2023 and 2024, PT Jayamas Medica has paid IDR6.05 with an average of IDR3.03 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for PT Jayamas Medica 10 years ago, but if you had invested on Tuesday 8th of November 2022 when the price was IDR252.00, you would have made a loss of IDR-72.00 per share or -28.57%

Yes, the average daily trading liquidity for PT Jayamas Medica is IDR5.50 million. You should therefore be able to get in and out of your positions relatively fast.

PT Jayamas Medica has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.98, the company's ability to pay off the debt is good. PT Jayamas Medica has a good net profit margin of 15.69% and should have high tolerances against inflation.

We have calculated the inflation risk for PT Jayamas Medica to be low [0.1 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.